Aytu BioScience (AYTU) Misses Q2 EPS by 105c

Aytu BioScience (NASDAQ: AYTU) reported Q2 EPS of ($1.05), $1.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $15.2 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Downgrades KFin Technologies Ltd (KFINTECH:IN) to Neutral
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters